Abbott Seeks To Enroll 1,670 Patients In ZoMaxx DES Trial By Summer 2006
This article was originally published in The Gray Sheet
Executive Summary
Abbott has enrolled 100 of 1,670 patients for its ZOMAXX II pivotal trial, putting it on track for a 2008 U.S. launch